Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Cullinan Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 135 | 1 | 137 | +3 |
| Shares | 62.9M | 3.55M | 65.0M | +5.63M (+9.5%) |
| Value | $1.10B | $61.9M | $1.09B | +$51.6M (+5.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,338,725 | $72.6M | 0.00% |
| Siren, L.L.C. | 1,211,357 | $20.3M | 1.01% |
| Patient Square Capital LP | 824,705 | $13.8M | 5.12% |
| Millennium Management LLC | 788,567 | $13.2M | 0.01% |
| Sphera Funds Management Ltd. | 185,871 | $3.11M | 0.51% |
| Verition Fund Management LLC | 36,624 | $613.1K | 0.00% |
| HighVista Strategies LLC | 31,893 | $533.9K | 0.18% |
| Caption Management, LLC | 23,000 | $385.0K | 0.04% |
| Superstring Capital Management LP | 20,840 | $348.9K | 0.31% |
| Intech Investment Management LLC | 17,487 | $292.7K | 0.00% |
| Long Corridor Asset Management Ltd | 15,000 | $251.1K | 0.22% |
| ProShare Advisors LLC | 13,202 | $221.0K | 0.00% |
| Engineers Gate Manager LP | 12,245 | $205.0K | 0.00% |
| Simplex Trading, LLC | 7,623 | $127.0K | 0.00% |
| Public Employees Retirement Association of Colorado | 1,150 | $19.0K | 0.00% |
| Acadian Asset Management LLC | 956 | $16.0K | 0.00% |
| nVerses Capital, LLC | 600 | $10.0K | 0.00% |
| Bessemer Group Inc | 105 | $2.00K | 0.00% |
| Sterling Capital Management LLC | 59 | $988 | 0.00% |
| Capital Performance Advisors LLP | 13 | $218 | 0.00% |
Sold out (17)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Cormorant Asset Management, LP | 1,125,000 | $19.6M |
| Artal Group S.A. | 1,057,949 | $18.5M |
| Perceptive Advisors LLC | 749,916 | $13.1M |
| Qube Research & Technologies Ltd | 190,520 | $3.32M |
| Voloridge Investment Management, LLC | 163,047 | $2.84M |
| Balyasny Asset Management LLC | 150,708 | $2.63M |
| First Trust Advisors LP | 136,887 | $2.39M |
| Jacobs Levy Equity Management, Inc | 98,296 | $1.71M |
| Russell Investments Group, Ltd. | 34,293 | $598.1K |
| STRS Ohio | 34,100 | $594.7K |
| Sherbrooke Park Advisers LLC | 25,976 | $453.0K |
| Alpine Global Management, LLC | 12,164 | $212.1K |
| Cornercap Investment Counsel Inc | 11,491 | $200.4K |
| Public Employees Retirement System of Ohio | 2,847 | $49.7K |
| Pacer Advisors, Inc. | 595 | $10.4K |
| Advisor Group Holdings, Inc. | 50 | $872 |
| Group One Trading, L.P. | 14 | $244 |
Not filed for Q3 2024 yet (1)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,550,207 | $61.9M |